Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
A20020007	硝呋太尔	nifuratel	Active ingredient	Chemical Drugs	New Drug Application	2004-02-18	普利化学工业公司北京代表处	Polichem SRLBeijing	Approval Completed-Pending Certificated		view
A20020006	匹多莫德	pidotimod	Active ingredient	Chemical Drugs	New Drug Application	2004-05-26	普利化学工业公司北京代表处	Polichem SRLBeijing	In Approval		view
JYHB1601394	依巴斯汀片	ebastine	Tablet	Chemical Drugs	Supplementary Application	2016-10-25	瑞士普利化学工业公司北京代表处	Polichem SRLBeijing;Almirall SA;Industrias Farmaceuticas Almirall Prodesfarma SL	Certificate Issued	2018-06-29	view
JYHZ1800249	依巴斯汀片	ebastine	Tablet	Chemical Drugs	License Renew	2018-08-16	瑞士普利化学工业公司北京代表处	Polichem SRLBeijing;Almirall SA	Certificate Issued	2019-08-13	view
JYHB1901638	依巴斯汀片	ebastine	Tablet	Chemical Drugs	Supplementary Application	2020-01-23	瑞士普利化学工业公司北京代表处	Polichem SRLBeijing;Almirall SA;Industrias Farmaceuticas Almirall Prodesfarma SL	In Review	2020-01-22	view
JYHZ2000152	匹多莫德口服液	pidotimod	Oral solution	Chemical Drugs	License Renew	2020-06-25	瑞士普利化学工业公司北京代表处	Polichem SRLBeijing;Polichem Srl;Doppel Farmaceutical Srl	In Review	2020-06-24	view
JYHZ2000032	硝呋太尔阴道片	nifuratel	Tablet	Chemical Drugs	License Renew	2020-03-18	瑞士普利化学工业公司北京代表处	Polichem SRLBeijing;Polichem Srl;Doppel Farmaceutical Srl	Certificate Issued	2021-03-17	view